Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients

Renal Failure

Volumn 32, Issue 6, 2010, Pages 716-720

  Temiz, Gokhan ^a   Kasifoglu, Nilgun ^a   Kiris, Alpay ^b   Ozturk, Sultan ^a   Sahin, Garip ^a   Yalcin, Ahmet Ugur ^a   Us, Tercan ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b RTS Yasam Diyaliz Merkezi   (Turkey)

Author keywords

Hemodialysis; Immune response; Pandemic influenza; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; INFLUENZA VACCINE;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COST CONTROL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; ANTIBODY FORMATION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 77953606960     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486498     Document Type: Article

References (17)

1. Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl. 2001;78:206-211.
2. World Health Organization. Pandemic (H1N1) 2009 - Update 82. http://www.who.int/csr/don/2010-01-08/en/index.html. Accessed January 11, 2010.
3. United States Centers for Disease Control and Prevention. 2009-2010 influenza season week 52 ending January 2, 2010. http://www.cdc.gov/flu/weekly/. Accessed January 11, 2010.
4. Vaillant L, La Ruche G, Tarantola A, Barboza P, epidemic Intelligence Team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14:19309.
5. Köhler H, Girndt M, Dumann H, Klingel R. Immundefekt bei Niereninsuffizienz. Deutsche medizinische Wochenschrift. 1993;118:790-795.
6. Girndt M, Köhler H, Schiedhelm-Weick E, Meyerzum Büschenfelde KH, Fleischer B. T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathway. Kidney Int. 1993;44:359-365.
7. Cappel R, Van Beers D, Liesnard C, Dratwa M. Impaired humoral and cell-mediated immune response in dialyzed patients after influenza vaccination. Nephron. 1983;33:21-25.
8. Brokstad KA, Cox RJ, Major D, Wood JM, Haaheim LR. Cross-reactivity but no avidity change of the serum antibody response after influenza vaccination. Vaccine. 1995;13: 1522-1528.
9. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A (H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol. 2000;61:94-99.
10. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20:440-451.
11. CDC. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep. 2005;54(No.RR-8):1-40.
12. Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, Kim WJ. Active influenza immunization in hemodialysis patients: Comparison between single-dose and booster vaccination. Am J Nephrol. 2006;26:206-211.
13. Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep. 2009;58:521-524.
14. Antonen JA, Pyhala R, Hannula PM, et al. Influenza vaccination of dialysis patients: Cross-reactivity of induced hemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults. Nephrol Dial Transplant. 2003;18:777-781.
15. Pifer J, Hennes JL, Lee JM, Witte PL. Age-related differences in the immune response to immunization with human Abeta42 peptide. J Gerontol A Biol Sci Med Sci. 2002;57:B355-B358.
16. Lonneman G, Novick D, Rubinstein M, Passlick-Deetjen J, Lang D, Dinarello CA. A switch to high-flux helixone membranes reverses suppressed interferon gamma production in patients on low-flux dialysis. Blood Purif. 2003;21:225-231.
17. Schiffl H, Wendinger H, Lang SM. Ultrapure dialysis fluid and response to hepatitis B vaccine. Nephron. 2001;91:530-531.